Clinical trial
3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic…
NCT00077545 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00077545 |
|---|---|
| Title | 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction |
| Official title | A Phase II Study Of Triapine In Combination With Cisplatin Esophageal Carcinoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Esophagus, Recurrent Esophageal Cancer, Stage IV Esophageal Cancer |
| Intervention type | Drug |
| Interventions | triapine, cisplatin |
| Enrollment | 39 |
| Start date | Jan 1, 2004 |
| Primary completion | Mar 1, 2007 |
| First posted | Feb 12, 2004 |
| Last update posted | Oct 8, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: